Commonwealth Equity Services, LLC Amphastar Pharmaceuticals, Inc. Transaction History
Commonwealth Equity Services, LLC
- $66 Billion
- Q3 2024
A detailed history of Commonwealth Equity Services, LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 5,651 shares of AMPH stock, worth $301,763. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,651
Previous 10,190
44.54%
Holding current value
$301,763
Previous $408,000
32.84%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding AMPH
# of Institutions
282Shares Held
35.2MCall Options Held
25.5KPut Options Held
24.8K-
Black Rock Inc. New York, NY5.94MShares$317 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$143 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$114 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.94MShares$104 Million0.19% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$86.6 Million0.05% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.62B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...